These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5633532)

  • 1. [Low molecular weight dextran and fibrinolysis in humans. I. Comparison between fibrinolysis activation by administering low molecular weight dextran by intravenous and intra-arterial routes].
    Tesi M; Brunetti S; Caramelli L
    Riv Crit Clin Med; 1967 Aug; 67(3):200-15. PubMed ID: 5633532
    [No Abstract]   [Full Text] [Related]  

  • 2. [Low molecular weight dextran and fibrinolysis in men. II. Fibrinolysis activation by administering low molecular weight dextran in lymphedema].
    Tesi M; Brunetti S
    Riv Crit Clin Med; 1967 Aug; 67(3):216-32. PubMed ID: 5633533
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of various drugs on the dynamics of fibrinolysis in humans].
    Brunetti S; Tesi M
    Riv Crit Clin Med; 1967 Aug; 67(3):233-45. PubMed ID: 5633715
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of drugs and parenteral solutions on vascular fibrinolytic activity.
    Johnston WE; Silver D
    Surgery; 1975 Aug; 78(2):202-10. PubMed ID: 1154264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran.
    Cunliffe WJ; Menon IS
    Br J Dermatol; 1969 Mar; 81(3):220-5. PubMed ID: 5775073
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of infusion of dextran 70 on fibrinolysis inhibition activity in human serum.
    Carlin G; Modig J; Saldeen T
    Acta Chir Scand; 1979; 145(3):129-31. PubMed ID: 494957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nicotinic acid and fibrinolysis in humans. II. Tachyphylaxis and dynamic fibrinolytic reactivation (general and regional), caused by "venous" and "arterial" administration of nicotinic acid].
    Tesi M; Brunetti S; Caramelli L
    Riv Crit Clin Med; 1967 Dec; 67(6):484-507. PubMed ID: 5603692
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blocking effect of atropine on fibrinolysis induced by acetylcholine and bradykinin].
    Tesi M; Brunetti S
    Riv Crit Clin Med; 1967 Aug; 67(3):256-70. PubMed ID: 5633534
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angiodynamic and fibrinolytic effect of eledoisin].
    Pratesi F; Tesi M; Brunetti S; Dabizzi RP; Caramelli L; Biddau A
    Actual Cardiol Angeiol Int (Paris); 1967; 16(4):319-25. PubMed ID: 5294005
    [No Abstract]   [Full Text] [Related]  

  • 10. [The influence of alpha-beta blocking agents on fibrinolysis induced by acetylcholine in humans].
    Brunetti S; Tesi M; Biddau A; Caramelli L
    Riv Crit Clin Med; 1967 Aug; 67(3):246-55. PubMed ID: 4395434
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the utilization, during peripheral angiographies, of a solution of polysaccharides of low molecular weight (40,000) derived from Dextran].
    Chassaigne JP; Voglimacci JP; Marque B; Tingaud R
    J Med Bord; 1967 Jan; 144(1):165-7. PubMed ID: 5597404
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of heparin and low molecular weight dextran on survival after fibrinopurulent peritonitis.
    Davidson RK; Cardenas A; Buruttil RW
    Surg Gynecol Obstet; 1981 Sep; 153(3):327-31. PubMed ID: 6168022
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombotic effect of hemodilution with dextran. Studies on the mechanism of action.
    Aberg M; Bergentz SE; Hedner U
    Bibl Haematol; 1975; (41):125-32. PubMed ID: 1180824
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the activation mechanism of fibrinolysis by dextran sulphate].
    Mihara H; Ichihashi M; Okamoto S
    Nihon Seirigaku Zasshi; 1970 Jan; 32(1):25-34. PubMed ID: 5462228
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intra-arterial therapy of peripheral arterial occlusive disease with oxyfedrine and low-molecular dextran].
    Cachovan M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1940-3. PubMed ID: 1030142
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with low molecular weight dextran in patients with thrombocytosis.
    Tytgat GN; De Vreker RA; Lust A
    Acta Anaesthesiol Belg; 1968; 19(2):183-92. PubMed ID: 5746328
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of dextran and gelatin infusion on the coagulation and fibrinolytic process in rabbits subjected to combined radiation injuries].
    Pantelić D; Ciko Z; Knezević O
    Zb Vojnomed Akad; 1976; (18):33-8. PubMed ID: 1074334
    [No Abstract]   [Full Text] [Related]  

  • 18. [Postoperative thrombosis of the vertebral artery--report of a case successfully treated with combination of a thrombolytic agent, low molecular dextran and an anticoagulant].
    Nagashima C
    No To Shinkei; 1970 Dec; 22(12):1419-27. PubMed ID: 5536834
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of 6 per cent dextran 70 Polfa transfusions on blood clotting and hemostasis].
    Rudowski W; Kostrzewska E; Meissner AJ; Lopaciuk S; Uszyński L
    Pol Tyg Lek; 1973 Oct; 28(41):1581-3. PubMed ID: 4765459
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of single intravenous infusion of low-molecular weight dextran on acid-base equilibrium and erythrocytes and some spirometric indices in chronic cor pulmonale syndrome].
    Gondorowicz K; Religa H; Rozniecki J
    Pol Tyg Lek; 1973 Mar; 28(13):469-72. PubMed ID: 4698724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.